Hyman Steven 4/A
4/A · Cyclerion Therapeutics, Inc. · Filed Jul 27, 2022
Insider Transaction Report
Form 4/AAmended
Hyman Steven
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-25+57,753→ 57,753 totalExercise: $0.78Exp: 2032-07-25→ Common Stock (57,753 underlying)
Footnotes (1)
- [F1]The options were granted pursuant to the director compensation plan. 17,753 options will vest in full on the first anniversary of the grant date and 40,000 options will vest monthly pro rata over 36 months starting on the grant date.